Menu
Back to Journals » Clinical Ophthalmology » Volume 6
Meridional lenticular astigmatism associated with bilateral concurrent uveal metastases in renal cell carcinoma
Authors Priluck J, Grover S, Chalam K
Received 19 August 2012
Accepted for publication 1 October 2012
Published 6 November 2012 Volume 2012:6 Pages 1839—1841
DOI https://doi.org/10.2147/OPTH.S37163
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 4
Joshua C Priluck, Sandeep Grover, KV Chalam
Department of Ophthalmology, University of Florida College of Medicine, Jacksonville, FL, USA
Purpose: To demonstrate a case illustrating meridional lenticular astigmatism as a result of renal cell carcinoma uveal metastases.
Methods: Case report with images.
Results: Clinical findings and diagnostic testing of a patient with acquired meridional lenticular astigmatism are described. The refraction revealed best-corrected visual acuity of 20/20–1 OD (−2.50 + 0.25 × 090) and 20/50 OS (−8.25 + 3.25 × 075). Bilateral concurrent renal cell carcinoma metastases to the choroid and ciliary body are demonstrated by utilizing ultrasonography, ultrawidefield fluorescein angiography, and unique spectral-domain optical coherence tomography.
Conclusions: Metastatic disease should be included in the differential of acquired astigmatism. Spectral-domain optical coherence tomography, ultrawidefield fluorescein angiography, and ultrasonography have roles in delineating choroidal metastases.
Keywords: astigmatism, metastasis, optical coherence tomography, renal cell carcinoma
© 2012 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.